Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Clin Pharmacol ; 84(7): 1611-1616, 2018 07.
Article in English | MEDLINE | ID: mdl-29667234

ABSTRACT

The anaphylactoid reaction described follows cessation of ranitidine in a 19-year-old female with the disease cluster: mast cell activation syndrome, hypermobile Ehlers-Danlos syndrome and postural tachycardia syndrome. Anaphylaxis can give wide-ranging symptoms from rhinorrhoea and urticaria to tachycardia and system-wide, life-threatening, anaphylactic shock. Individuals with a disorder of mast cell activation can experience many such symptoms. H2 receptor antagonists, such as ranitidine, are commonly prescribed in this population. A mechanism for the reaction is proposed in the context of ranitidine, as an inverse agonist, causing upregulation of H2 histamine receptors and raised histamine levels due to enzyme induction. This effect, following extended and/or high antihistamine dosing, may have implications for other individuals with a disorder of mast cell activation, such as mastocytosis or mast cell activation syndrome. There are potential policy and patient guidance implications for primary and secondary care with respect to cessation of H2 antagonists.


Subject(s)
Anaphylaxis/immunology , Histamine/blood , Receptors, Histamine H2/metabolism , Withholding Treatment , Adult , Anaphylaxis/blood , Anaphylaxis/diagnosis , Anaphylaxis/drug therapy , Chlorpheniramine/therapeutic use , Epinephrine/administration & dosage , Female , Histamine/immunology , Histamine H1 Antagonists/therapeutic use , Histamine H2 Antagonists/administration & dosage , Humans , Ranitidine/administration & dosage , Receptors, Histamine H2/immunology , Treatment Outcome , Up-Regulation , Young Adult
2.
Eur J Pharmacol ; 654(2): 173-80, 2011 Mar 05.
Article in English | MEDLINE | ID: mdl-21172338

ABSTRACT

Agonist-induced internalisation of receptors may lead to the formation of signalling endosomes. There is little evidence relating to whether this occurs to native receptors in non-transformed cells, and no previous studies asking whether this endosomal signalling can promote cell cycle progression in non-transformed cells. We investigated the hypothesis that in primary hepatocytes clathrin-dependent epidermal growth factor (EGF)-induced internalisation of the EGF receptor leads to signalling from endosomal EGF-EGF receptor complexes which may support EGF-stimulated cell cycle progression. We used EGF-stimulation of rat hepatocytes followed by confocal microscopy, and Western blots for phosphoproteins. [(3)H]thymidine incorporation into DNA was used as a indicator of progression to S-phase. Confocal microscopy demonstrated co-internalisation of EGF, EGF receptors and transferrin into endosomes. Internalisation of EGF/EGF receptor/transferrin was blocked by expression of dominant-negative dynamin, but not by the tyrosine kinase inhibitor AG 1478. Dominant-negative dynamin expression reduced EGF-stimulated extracellular signal-related kinase and Akt signalling, but increased tyrosine phosphorylated EGF receptor. EGF-stimulated cell cycle progression requires stimulation of EGF receptors during an initial period (e.g. 1h) and also later during a 24h incubation. EGF receptor internalisation in the presence of AG 1478 followed by removal of the inhibitor resulted in signalling from internalised EGF receptors that is sufficient for the initial stimulation to provide progression to S-phase of the cell cycle. These observations on hepatocytes characterise, for the first time in non-transformed cells, endosomal signalling from internalised EGF receptors, and provide evidence that this endosomal signalling may support the early phase of EGF-stimulated cell cycle progression.


Subject(s)
Cell Cycle , Endosomes/metabolism , Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Hepatocytes/metabolism , Protein Kinase Inhibitors/pharmacology , Tyrphostins/pharmacology , Animals , Cell Cycle/drug effects , Cell Division/drug effects , Epidermal Growth Factor/pharmacology , Hepatocytes/cytology , Hepatocytes/drug effects , Male , Microscopy, Confocal , Protein Kinase Inhibitors/metabolism , Quinazolines , Rats , Rats, Wistar , Signal Transduction/drug effects , Thymidine/metabolism
3.
BMC Bioinformatics ; 9: 139, 2008 Mar 04.
Article in English | MEDLINE | ID: mdl-18318909

ABSTRACT

BACKGROUND: The topology of signaling cascades has been studied in quite some detail. However, how information is processed exactly is still relatively unknown. Since quite diverse information has to be transported by one and the same signaling cascade (e.g. in case of different agonists), it is clear that the underlying mechanism is more complex than a simple binary switch which relies on the mere presence or absence of a particular species. Therefore, finding means to analyze the information transferred will help in deciphering how information is processed exactly in the cell. Using the information-theoretic measure transfer entropy, we studied the properties of information transfer in an example case, namely calcium signaling under different cellular conditions. Transfer entropy is an asymmetric and dynamic measure of the dependence of two (nonlinear) stochastic processes. We used calcium signaling since it is a well-studied example of complex cellular signaling. It has been suggested that specific information is encoded in the amplitude, frequency and waveform of the oscillatory Ca(2+)-signal. RESULTS: We set up a computational framework to study information transfer, e.g. for calcium signaling at different levels of activation and different particle numbers in the system. We stochastically coupled simulated and experimentally measured calcium signals to simulated target proteins and used kernel density methods to estimate the transfer entropy from these bivariate time series. We found that, most of the time, the transfer entropy increases with increasing particle numbers. In systems with only few particles, faithful information transfer is hampered by random fluctuations. The transfer entropy also seems to be slightly correlated to the complexity (spiking, bursting or irregular oscillations) of the signal. Finally, we discuss a number of peculiarities of our approach in detail. CONCLUSION: This study presents the first application of transfer entropy to biochemical signaling pathways. We could quantify the information transferred from simulated/experimentally measured calcium signals to a target enzyme under different cellular conditions. Our approach, comprising stochastic coupling and using the information-theoretic measure transfer entropy, could also be a valuable tool for the analysis of other signaling pathways.


Subject(s)
Algorithms , Information Storage and Retrieval/methods , Models, Biological , Proteins/metabolism , Signal Transduction/physiology , Computer Simulation , Models, Statistical , Stochastic Processes
4.
Biophys Chem ; 132(1): 33-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17964062

ABSTRACT

Calcium has been established as a key messenger in both intra- and intercellular signaling. Experimentally observed intracellular calcium responses to different agonists show a variety of behaviors from simple spiking to complex oscillatory regimes. Here we study typical experimental traces of calcium oscillations in hepatocytes obtained in response to phenylephrine and ATP. The traces were analyzed with methods of nonlinear time series analysis in order to determine the stochastic/deterministic nature of the intracellular calcium oscillations. Despite the fact that the oscillations appear, visually, to be deterministic yet perturbed by noise, our analyses provide strong evidence that the measured calcium traces in hepatocytes are prevalently of stochastic nature. In particular, bursting calcium oscillations are temporally correlated Gaussian series distorted by a monotonic, instantaneous, time-independent function, whilst the spiking behavior appears to have a dynamical nonlinear component whereby the overall determinism level is still low. The biological importance of this finding is discussed in relation to the mechanisms incorporated in mathematical models as well as the role of stochasticity and determinism at cellular and tissue levels which resemble typical statistical and thermodynamic effects in physics.


Subject(s)
Calcium Signaling , Calcium/analysis , Models, Biological , Adenosine Triphosphate/pharmacology , Animals , Calcium/metabolism , Calcium Signaling/drug effects , Cytosol/chemistry , Cytosol/metabolism , Hepatocytes/chemistry , Hepatocytes/drug effects , Hepatocytes/metabolism , Phenylephrine/pharmacology , Rats , Rats, Wistar
5.
J Pharmacol Exp Ther ; 321(3): 884-91, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17371807

ABSTRACT

Epidermal growth factor (EGF) stimulation of cell cycle progression in cultured primary hepatocytes has previously been reported to be dependent on the mammalian target of rapamycin (mTOR) elements of the phosphoinositide 3-kinase (PI3K) signaling cascade and not the Akt pathway. Here we have established conditions of combined treatment of rat hepatocytes with insulin and EGF that favor cell cycle progression. The resulting cell population expresses albumin and retains receptor regulation of the signaling pathways leading to glycogen phosphorylase activation. We then investigated the hypothesis that the Akt limb of the PI3K pathway plays a central role in this insulin/EGF enhancement of cell cycle progression. The phosphorylation of Akt, central to the PI3K pathway, was increased by both insulin (sustained) and EGF (transient). The stimulation of Akt phosphorylation was inhibited in a concentration-dependent manner by the PI3K inhibitor, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Cell cycle progression in these cultures was reduced, but not abolished, by this inhibitor. The mTOR inhibitor, rapamycin, also inhibited entry into S phase. The novel Akt inhibitor A-443654 [(S)-1-(1H-indol-3-ylmethyl)-2-[5-(3-methyl-1H-indazol-5-yl)-pyridin-3-yloxy]-ethylamine] blocked both EGF-stimulated cell cycle progression and phosphorylation of the Akt substrate glycogen synthase kinase-3. Infection of cells with an adenoviral vector expressing a constitutively active form of Akt but not a kinase-dead form increased hepatocyte proliferation probably through enhanced cell cycle progression and reduced apoptosis. These results show that the Akt element of the PI3K cascade is necessary for EGF-stimulated cell cycle progression and provide evidence that the sustained elevation of Akt alone generates a hyperproliferative window in hepatocyte cultures.


Subject(s)
Cell Cycle/physiology , Epidermal Growth Factor/pharmacology , Hepatocytes/metabolism , Proto-Oncogene Proteins c-akt/physiology , Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Adenosine Triphosphate/pharmacology , Adenoviridae/genetics , Animals , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Glycogen Phosphorylase/metabolism , Hepatocytes/cytology , Hepatocytes/drug effects , Inositol Phosphates/metabolism , Insulin/pharmacology , Male , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Protein Kinases/metabolism , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/genetics , Rats , Rats, Wistar , S Phase/drug effects , TOR Serine-Threonine Kinases , Thionucleotides/pharmacology , Transfection , Uridine Diphosphate/pharmacology , Uridine Triphosphate/pharmacology
6.
Biophys J ; 89(3): 1603-11, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15994893

ABSTRACT

Simulation and modeling is becoming more and more important when studying complex biochemical systems. Most often, ordinary differential equations are employed for this purpose. However, these are only applicable when the numbers of participating molecules in the biochemical systems are large enough to be treated as concentrations. For smaller systems, stochastic simulations on discrete particle basis are more accurate. Unfortunately, there are no general rules for determining which method should be employed for exactly which problem to get the most realistic result. Therefore, we study the transition from stochastic to deterministic behavior in a widely studied system, namely the signal transduction via calcium, especially calcium oscillations. We observe that the transition occurs within a range of particle numbers, which roughly corresponds to the number of receptors and channels in the cell, and depends heavily on the attractive properties of the phase space of the respective systems dynamics. We conclude that the attractive properties of a system, expressed, e.g., by the divergence of the system, are a good measure for determining which simulation algorithm is appropriate in terms of speed and realism.


Subject(s)
Biophysics/methods , Calcium Signaling , Calcium/chemistry , Adenosine Triphosphate/chemistry , Algorithms , Animals , Biochemistry/methods , Calcium/metabolism , Collagenases/metabolism , Computer Simulation , Hepatocytes/cytology , Kinetics , Male , Models, Biological , Models, Statistical , Models, Theoretical , Oscillometry , Perfusion , Rats , Rats, Wistar , Signal Transduction , Stochastic Processes , Systems Theory , Time Factors
7.
J Pharmacol Exp Ther ; 313(3): 1305-13, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15764738

ABSTRACT

In the rat both short-term liver function, such as glycogen metabolism, and long-term events such as proliferation after partial hepatectomy, are in part controlled by release of nucleotides such as ATP acting on hepatocyte P2Y(1) and P2Y(2) receptors (members of a family of P2Y receptors for extracellular nucleotides such as ATP and UTP). Here, we have studied P2Y receptor regulation of signaling pathways involved in glycogen phosphorylase activation and proliferation of primary human hepatocytes. Stimulation of cultured hepatocytes with either ATP and UTP, but not UDP or 2-methylthio ADP, led to concentration-dependent increases in cytosolic free Ca(2+) concentration ([Ca(2+)](c); EC(50) for ATP = 3.3 microM, for UTP = 2.3 microM) and [(3)H]inositol (poly)phosphates (EC(50) for ATP = 9.4 microM, for UTP = 15.4 microM). ATP and UTP also stimulated glycogen phosphorylase in human hepatocytes, each with a threshold for activation of less than 1 microM. Application of 2-methylthio ADP up to 100 microM was ineffective. Phosphorylation of both extracellular signal-related kinase and c-Jun N-terminal kinase was stimulated by ATP and UTP, but not by 2-methylthio ADP or UDP, either alone or when costimulated with epidermal growth factor. In conclusion, in human hepatocytes P2Y receptors control both glycogen metabolism and proliferation-associated responses such as increased [Ca(2+)](c) and mitogen-activated protein kinase cascades. Regulation seems to be primarily through P2Y(2) receptors. In contrast with previous studies on rat hepatocytes, there is an absence of responses mediated by P2Y(1) receptors.


Subject(s)
Calcium/metabolism , Glycogen Phosphorylase/physiology , Hepatocytes/metabolism , MAP Kinase Signaling System/physiology , Receptors, Purinergic P2/physiology , Adenosine Triphosphate/pharmacology , Cells, Cultured , Cyclic AMP/metabolism , Enzyme Activation , Humans , JNK Mitogen-Activated Protein Kinases/physiology , Receptors, Purinergic P2Y1 , Receptors, Purinergic P2Y2 , Uridine Triphosphate/pharmacology
8.
J Pharmacol Exp Ther ; 311(1): 334-41, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15152027

ABSTRACT

Hepatocyte function is regulated by several P2Y receptor subtypes. Here we report that 2-methylthioadenosine 5'-diphosphate (2-MeSADP), an agonist at P2Y(1), P2Y(12), and P2Y(13) receptors, potently (threshold 30 nM) stimulates glycogen phosphorylase in freshly isolated rat hepatocytes. Antagonism by N(6)-methyl 2'-deoxyadenosine 3',5'-bisphosphate (MRS 2179) confirms that this response is mediated by P2Y(1) receptors. In addition, in these cells, both 2-MeSADP and UTP inhibited glucagon-stimulated cyclic AMP accumulation. This inhibitory effect of 2-MeSADP was not reversed by the P2Y(1) antagonists, adenosine-3'-phosphate-5'-phosphate (A3P5P) or MRS 2179, both in the range 1 to 300 microM, indicating that it was not mediated by P2Y(1) receptors. This contrasts with the increase in cytosolic free Ca(2+) concentration ([Ca(2+)](c)) induced by 2-MeSADP, which has shown to be inhibited by A3P5P. Pertussis toxin abolished the inhibitory effect of both UTP and 2-MeSADP. After culture of cells for 48 h, the ability of 2-MeSADP to inhibit cyclic AMP accumulation was greatly diminished. Reverse transcriptase-polymerase chain reaction analysis revealed that during this culture period, there was a decline in the ability to detect transcripts for P2Y(12) and P2Y(13) receptors, both of which are activated by 2-MeSADP and negatively coupled to adenylyl cyclase. However, in freshly isolated cells, the P2Y(12) and P2Y(13) receptor antagonist, 2-propylthio-beta,gamma-dichloromethylene-d-ATP (AR-C67085) (10 nM to 300 microM) did not alter the ability of 2-MeSADP to inhibit glucagon-stimulated cyclic AMP accumulation. We conclude that 2-MeSADP regulates rat hepatocyte glycogen phosphorylase by acting on P2Y(1) receptors coupled to raised [Ca(2+)](c), and by inhibiting cyclic AMP levels by an unknown G(i)-coupled receptor subtype, distinct from P2Y(1), P2Y(12), or P2Y(13) receptors.


Subject(s)
Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Adenosine Monophosphate/analogs & derivatives , Cyclic AMP/metabolism , Glycogen Phosphorylase/metabolism , Hepatocytes/drug effects , Receptors, Purinergic P2/metabolism , Adenosine Monophosphate/pharmacology , Animals , Cells, Cultured , Enzyme Activation , Hepatocytes/enzymology , Hepatocytes/metabolism , Male , Protein Isoforms/genetics , Protein Isoforms/metabolism , Purinergic P2 Receptor Antagonists , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2/physiology , Receptors, Purinergic P2Y1 , Uridine Triphosphate/metabolism
9.
Br J Pharmacol ; 138(1): 272-8, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12522099

ABSTRACT

1 Accumulation of inositol (poly)phosphates (InsP(x)) has been studied in rat hepatocytes labelled with [(3)H]inositol. Stimulation with ADP resulted in a significant increase in total [(3)H]InsP(x), whereas 2-MeSADP had only a small effect and ADPbetaS was ineffective. UTP and ITP also stimulated substantial increases in [(3)H]InsP(x). 2 The dose-response curve to ADP was largely unaltered by the presence of the P2Y(1) antagonist, adenosine-3'-phosphate-5'-phosphate (A3P5P). Similarly, inclusion of MRS 2179, a more selective P2Y(1) antagonist, had no effect on the dose-response curve to ADP. 3 The inclusion of hexokinase in the assay reduced, but did not abolish, the response to ADP. 4 HPLC analysis revealed that ADP in the medium was rapidly converted to AMP and ATP. The inclusion of hexokinase removed ATP, but exacerbated the decline in ADP concentration, leading to increased levels of AMP. 2-MeSADP was stable in the medium and ATP was largely unaffected. 5 The addition of the adenylate kinase inhibitor, diadenosine pentaphosphate (Ap(5)A) significantly reduced the ADP response. HPLC analysis conducted in parallel demonstrated that this treatment inhibited conversion of ADP to ATP and AMP. 6 Inclusion of the P1 antagonist CGS 15943 had no effect on the dose-response curve to ADP. 7 These observations indicate that hepatocytes respond to ADP with an increase in inositol (poly)phosphates following conversion to ATP. P2Y(1) activation in hepatocytes does not appear to be coupled to inositol 1,4,5-trisphosphate (Ins(1,4,5)P(3)) production.


Subject(s)
Adenosine Diphosphate/physiology , Adenosine Triphosphate/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Inositol Phosphates/metabolism , Receptors, Purinergic P2/metabolism , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/physiology , Animals , Dose-Response Relationship, Drug , Hepatocytes/physiology , Inositol Phosphates/physiology , Male , Purinergic P2 Receptor Agonists , Rats , Rats, Wistar , Receptors, Purinergic P2Y2
SELECTION OF CITATIONS
SEARCH DETAIL
...